Send to

Choose Destination
Cancer Med. 2018 Aug;7(8):3848-3861. doi: 10.1002/cam4.1537. Epub 2018 Jun 28.

A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response.

Author information

Department of laboratory medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
Shenzhen Key Laboratory of Viral Oncology, the Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Westlake University, Hangzhou, Zhejiang, China.
Institute of Aging Research and the Affiliated Hospital, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang, China.
School of Life Sciences, Fudan University, Shanghai, China.
Department of Pathology, School of Medicine, The Children Hospital of Zhejiang University, Hangzhou, China.
Institute of Dermatology and Department of Dermatology, No. 1 Hospital, Anhui Medical University, Hefei, Anhui, China.
Cancer Research Institute and the Provincial Key Laboratory of Functional Proteomics, Southern Medical University, Guangzhou, China.
Beijing Genome Institute (BGI), Shenzhen, China.
School of Biotechnology of Southern Medical University, Guangzhou, China.
Clinical Laboratory, Nanfang Hospital of Southern Medical University, Guangzhou, China.
Department of Otolaryngology-Head and Neck Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Department of Pathology, Qingyuan People's Hospital, Qingyuan, China.
School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Department of Pathology, Nanfang Hospital of Southern Medical University, Guangzhou, China.
The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Suzhou Science& Technology Town Hospital, Suzhou Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu, China.
Jiangxi Medical College, Shangrao, Jiangxi, China.
School of Life Science, Beijing Institute of Technology, Beijing, China.
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
Department of Otolaryngology-Head and Neck Surgery, 303 Hospital of People's Liberation Army of China, Nanning, China.


The major histocompatibility complex (MHC) is most closely associated with nasopharyngeal carcinoma (NPC), but the complexity of its genome structure has proven challenging for the discovery of causal MHC loci or genes. We conducted a targeted MHC sequencing in 40 Cantonese NPC patients followed by a two-stage replication in 1065 NPC cases and 2137 controls of Southern Chinese descendent. Quantitative RT-PCR analysis (qRT-PCR) was used to detect gene expression status in 108 NPC and 43 noncancerous nasopharyngeal (NP) samples. Luciferase reporter assay and chromatin immunoprecipitation (ChIP) were used to assess the transcription factor binding site. We discovered that a novel SNP rs117565607_A at TRIM26 displayed the strongest association (OR = 1.909, Pcombined = 2.750 × 10-19 ). We also observed that TRIM26 was significantly downregulated in NPC tissue samples with genotype AA/AT than TT. Immunohistochemistry (IHC) test also found the TRIM26 protein expression in NPC tissue samples with the genotype AA/AT was lower than TT. According to computational prediction, rs117565607 locus was a binding site for the transcription factor Yin Yang 1 (YY1). We observed that the luciferase activity of YY1 which is binding to the A allele of rs117565607 was suppressed. ChIP data showed that YY1 was binding with T not A allele. Significance analysis of microarray suggested that TRIM26 downregulation was related to low immune response in NPC. We have identified a novel gene TRIM26 and a novel SNP rs117565607_A associated with NPC risk by regulating transcriptional process and established a new functional link between TRIM26 downregulation and low immune response in NPC.


TRIM26 ; immune response; nasopharyngeal carcinoma; single-nucleotide polymorphisms; targeted MHC sequencing

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center